GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 133 filers reported holding GOSSAMER BIO INC in Q2 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $210,000 | +44.8% | 17,496 | +0.7% | 0.08% | +55.6% |
| Q2 2022 | $145,000 | +10.7% | 17,370 | +15.5% | 0.05% | -8.5% |
| Q1 2022 | $131,000 | -27.2% | 15,039 | -5.6% | 0.06% | -13.2% |
| Q4 2021 | $180,000 | -40.6% | 15,932 | -33.9% | 0.07% | -48.9% |
| Q3 2021 | $303,000 | +47.1% | 24,110 | -4.9% | 0.13% | +56.5% |
| Q2 2021 | $206,000 | -21.7% | 25,361 | -10.9% | 0.08% | -23.4% |
| Q1 2021 | $263,000 | -2.6% | 28,463 | +1.8% | 0.11% | -0.9% |
| Q4 2020 | $270,000 | -13.5% | 27,963 | +11.3% | 0.11% | -31.7% |
| Q3 2020 | $312,000 | -15.9% | 25,129 | -12.0% | 0.16% | -6.8% |
| Q2 2020 | $371,000 | +157.6% | 28,554 | +101.6% | 0.18% | +198.3% |
| Q1 2020 | $144,000 | -43.3% | 14,166 | -12.8% | 0.06% | +40.5% |
| Q4 2019 | $254,000 | +21.5% | 16,245 | +30.2% | 0.04% | 0.0% |
| Q3 2019 | $209,000 | -28.4% | 12,473 | -5.3% | 0.04% | -32.3% |
| Q2 2019 | $292,000 | – | 13,168 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |